ncRNA name
hsa-miR-21
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
PDCD4
Cancer name
Esophageal Cancer
Cancer site
Esophagus
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-21 affects the sensitivity of esophageal cancer to cisplatin through targeting PDCD4.
Tissue resource
human esophageal cancer cell lines TE-1
human esophageal cancer cell lines Eca109/DDP
human normal esophageal cell lines Het-1A
Experiment
Dual-luciferase reporter assay
Institute
American Type Culture Collection
Country
USA
Continent
North American